Island (ASX: ILA) is a drug repurposing company, focused on the rapid development of antiviral therapeutics for infectious diseases.
We have a lead asset – ISLA-101 - that was initially developed by our wholly-owned subsidiary, Isla Pharmaceuticals. ISLA-101 is a drug with a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and other mosquitoes (or vector) borne diseases.
Dengue fever is the very definition of an unmet medical need. While 390 million humans are infected each year, it is thought that around 30-50% of people with the disease do not present with symptoms, enabling the virus to spread within communities. Warming global climates are accelerating the presence of mosquito-borne viruses that can cause death to the US, Europe and Australia
There is no specific pharmaceutical treatment and the one vaccine which exists is available to a highly restricted audience.
Island has repurposed ISLA-101, an antiviral oral drug to treat mosquito-borne viruses (eg dengue fever / Zika) and intends to complete Phase II studies with a significantly de-risked clinical program.
Company Details
- Employees
- 3
- Address
- 697 Burke Road Camberwell,, Suite 201,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Race Oncology.
- HQ
- Melbourne, New South Wales
Island Pharmaceuticals Questions
Island Pharmaceuticals's website is https://www.islandpharmaceuticals.com/site/content/
Island Pharmaceuticals's LinkedIn profile is https://au.linkedin.com/company/island-pharmaceuticals
Island Pharmaceuticals has
3 employees.
View email and phone details for 3
employees at Island Pharmaceuticals.
Island Pharmaceuticals's industry is
Biotechnology Research
Island Pharmaceuticals's top competitors are
Bcal Diagnostics,
Opsin Biotherapeutics, Inc.,
Arovella Therapeutics Asx: Ala,
Etirarx,
Biontx,
Osteal Therapeutics,
Race Oncology,
Mwp Partners,
Almaden Genomics,
Singlecell Biotechnology.
Island Pharmaceuticals's categories are Biotechnology Research
